OBJECTIVE: To compare high energy fast neutron treatment with conventional megavoltage x ray treatment in the management of locally advanced pelvic carcinomas (of the cervix, bladder, prostate, and rectum). DESIGN: Randomised study from February 1986; randomisation to neutron treatment or photon treatment was unstratified and in the ratio of 3 to 1 until January 1988, when randomisation was in the ratio 1 to 1 and stratified by site of tumour. SETTING: Mersey regional radiotherapy centre at Clatterbridge Hospital, Wirral. PATIENTS: 151 patients with locally advanced, non-metastatic pelvic cancer (27 cervical, 69 of the bladder, seven prostatic, and 48 of the rectum). INTERVENTION: Randomisation to neutron treatment was stopped in February 1990. MAIN OUTCOME MEASURES: Patient survival and causes of death in relation to the development of metastatic disease and treatment related morbidity. RESULTS: In the first phase of the trial 42 patients were randomised to neutron treatment and 14 to photon treatment, and in the second phase 48 to neutron treatment and 47 to photon treatment. The relative risk of mortality for photons compared with neutrons was 0.66 (95% confidence interval 0.40 to 1.10) after adjustment for site of tumour and other important prognostic factors. Short term and long term complications were similar in both groups. CONCLUSIONS: The trial was stopped because of the increased mortality in patients with cancer of the cervix, bladder, or rectum treated with neutrons.
RCT Entities:
OBJECTIVE: To compare high energy fast neutron treatment with conventional megavoltage x ray treatment in the management of locally advanced pelvic carcinomas (of the cervix, bladder, prostate, and rectum). DESIGN: Randomised study from February 1986; randomisation to neutron treatment or photon treatment was unstratified and in the ratio of 3 to 1 until January 1988, when randomisation was in the ratio 1 to 1 and stratified by site of tumour. SETTING: Mersey regional radiotherapy centre at Clatterbridge Hospital, Wirral. PATIENTS: 151 patients with locally advanced, non-metastatic pelvic cancer (27 cervical, 69 of the bladder, seven prostatic, and 48 of the rectum). INTERVENTION: Randomisation to neutron treatment was stopped in February 1990. MAIN OUTCOME MEASURES: Patient survival and causes of death in relation to the development of metastatic disease and treatment related morbidity. RESULTS: In the first phase of the trial 42 patients were randomised to neutron treatment and 14 to photon treatment, and in the second phase 48 to neutron treatment and 47 to photon treatment. The relative risk of mortality for photons compared with neutrons was 0.66 (95% confidence interval 0.40 to 1.10) after adjustment for site of tumour and other important prognostic factors. Short term and long term complications were similar in both groups. CONCLUSIONS: The trial was stopped because of the increased mortality in patients with cancer of the cervix, bladder, or rectum treated with neutrons.
Authors: G E Laramore; J M Krall; F J Thomas; T W Griffin; M H Maor; F R Hendrickson Journal: Int J Radiat Oncol Biol Phys Date: 1985-09 Impact factor: 7.038
Authors: W Duncan; S J Arnott; W J Jack; R H MacDougall; P M Quilty; A Rodger; G R Kerr; J R Williams Journal: Int J Radiat Oncol Biol Phys Date: 1985-12 Impact factor: 7.038
Authors: M H Maor; B W Gillespie; L J Peters; A Wambersie; T W Griffin; F J Thomas; L Cohen; N Conner; P Gardner Journal: Int J Radiat Oncol Biol Phys Date: 1988-05 Impact factor: 7.038
Authors: Sheila M Bird; John Strang; Deborah Ashby; John Podmore; J Roy Robertson; Sarah Welch; Angela M Meade; Mahesh K B Parmar Journal: Contemp Clin Trials Commun Date: 2017-03
Authors: Hanno M Specht; Teresa Neff; Waltraud Reuschel; Franz M Wagner; Severin Kampfer; Jan J Wilkens; Winfried Petry; Stephanie E Combs Journal: Front Oncol Date: 2015-11-27 Impact factor: 6.244